Peter Snyder, Jr

Title: The Innovations of Peter Snyder, Jr.

Introduction

Peter Snyder, Jr. is a notable inventor based in Norristown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target viral infections. His work is characterized by a focus on innovative solutions to complex medical challenges.

Latest Patents

Peter Snyder, Jr. holds a patent for an anhydrous crystalline free base form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole. This crystalline form is particularly useful in treating infections caused by Picornaviridae, such as human rhinovirus (HRV). The patent also includes a method for manufacturing this crystalline form, which involves micronizing the compound particles and may include the use of a wetting agent. Additionally, it covers pharmaceutical compositions that incorporate this free base crystalline form, such as tablets or suspensions, along with methods for therapeutic treatments.

Career Highlights

Peter Snyder, Jr. is associated with Aviragen Therapeutics, Inc., where he continues to advance his research and development efforts. His work has led to the creation of innovative pharmaceutical solutions that address pressing health issues.

Collaborations

Throughout his career, Peter has collaborated with notable colleagues, including Edward Lee and David McAllister. These partnerships have contributed to the successful development of his patented innovations.

Conclusion

Peter Snyder, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of antiviral treatments, highlight the importance of research and development in improving public health.